GO:0030017 sarcomere: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030017 sarcomere is the repeating contractile unit of a myofibril in a muscle cell, composed of overlapping thick and thin filaments between two adjacent Z discs.
• Sarcomere dysfunction is a central mechanism in inherited cardiomyopathies, including hypertrophic and dilated cardiomyopathy, and in skeletal myopathies such as nemaline myopathy [2,5].
• The sarcomere is a highly ordered multiprotein machine whose assembly, maintenance, and turnover are regulated by post-translational modifiers such as the SUMO system.
• The M-band is an underestimated but critical sarcomere subregion that contributes to filament alignment, mechanical stability, and signaling.
• Sarcomere-mitochondrial communication is essential for metabolic homeostasis, and its disruption can drive dilated cardiomyopathy.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of sarcomere gene variants and sarcomere biology [2,3].
Description
The sarcomere (GO:0030017) is the fundamental contractile unit of striated muscle, defined as the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs. This highly ordered structure converts chemical energy into mechanical force and is responsible for muscle contraction in cardiac and skeletal muscle [2,5]. Because the sarcomere is a multiprotein assembly, even subtle changes in its components can alter force generation, signaling, and structural integrity [2,6]. Researchers study the sarcomere to understand muscle physiology, to dissect the molecular basis of inherited cardiomyopathies and myopathies, and to develop targeted therapeutics such as cardiac myosin inhibitors [2,7]. The sarcomere is also a model system for studying protein assembly, mechanotransduction, and organelle communication, including sarcomere-mitochondrial crosstalk [1,8]. Advances in CRISPR gene editing and functional genomics now allow precise perturbation of sarcomere genes in cellular and animal models, accelerating the translation of sarcomere biology into clinical insight [2,3].
sarcomere At A Glance
| GO ID | GO:0030017 |
|---|---|
| GO term | sarcomere |
| Ontology | cellular_component |
| Synonym | none |
| Definition | The repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs. |
| Major function | Force generation and contraction in cardiac and skeletal muscle through coordinated actin-myosin interactions [2,5]. |
| Key subregions | Z disc, I band, A band, M band, and the thick and thin filament arrays [2,6]. |
| Major protein classes | Myosin heavy chains, actin, troponin complex, tropomyosin, titin, myosin-binding protein C, and M-band proteins [2,5,6]. |
| Disease relevance | Inherited cardiomyopathies, nemaline myopathy, and other sarcomere-related muscle disorders [2,3,5]. |
What Is GO:0030017?
In the Gene Ontology, GO:0030017 sarcomere is a cellular component term defined as the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs. This definition captures the structural periodicity of the sarcomere and its central role as the basic contractile module of striated muscle [2,5].
Why Is sarcomere Important in Cell Biology?
The sarcomere is important because it is the ultimate effector of muscle contraction and a major locus of human disease. Mutations in sarcomere genes are among the most common causes of inherited hypertrophic and dilated cardiomyopathy, and they also underlie skeletal muscle disorders such as nemaline myopathy [2,3,5]. Beyond genetics, the sarcomere is a dynamic structure whose assembly, maintenance, and turnover are regulated by post-translational systems including SUMOylation, and whose function is tightly coupled to mitochondrial metabolism [1,8]. Understanding sarcomere biology therefore has direct implications for diagnosing and treating heart failure, arrhythmias, and myopathies, and for developing targeted therapeutics such as cardiac myosin inhibitors.
• Sarcomere variants are a leading cause of inherited hypertrophic cardiomyopathy and dilated cardiomyopathy [2,3].
• Sarcomere dysfunction is central to skeletal myopathies such as nemaline myopathy.
• The sarcomere is the target of emerging therapeutics including cardiac myosin inhibitors.
• Sarcomere-mitochondrial communication is required for metabolic homeostasis, and its disruption causes dilated cardiomyopathy.
• The M-band is a critical but understudied sarcomere subregion involved in filament alignment and signaling.
• SUMOylation regulates sarcomere organization and provides a mechanism for dynamic control of sarcomere assembly.
• Sarcomere divisions contribute to muscle growth, revealing unexpected plasticity in sarcomere number and organization.
• Low-penetrance sarcomere variants can contribute additive risk in hypertrophic cardiomyopathy, complicating genetic interpretation.
• Sarcomere genes are highly amenable to CRISPR modeling, enabling causal variant testing [2,3].
• Sarcomere research informs diagnostics, risk stratification, and precision therapies for cardiac and skeletal muscle disease [2,7].
Structure and Composition of sarcomere
Overview of the sarcomere as a repeating unit
In simple terms: The sarcomere is the basic repeating building block of muscle, like a tiny engine repeated many times along the muscle fiber.
The sarcomere is defined as the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs. This periodic organization gives striated muscle its characteristic banded appearance and allows coordinated contraction [2,5]. The sarcomere is flanked by Z discs, which anchor thin filaments and transmit force, and contains a central M band that cross-links thick filaments [2,6]. The precise stoichiometry and spatial arrangement of sarcomere proteins are essential for normal contractile function [2,5].
Thick filaments and myosin
In simple terms: Thick filaments are the motor elements of the sarcomere, made mainly of myosin, which pulls on thin filaments to shorten the muscle.
Thick filaments are primarily composed of myosin heavy chains and associated proteins such as myosin-binding protein C [2,5]. Cardiac myosin inhibitors that target the myosin motor have been developed for hypertrophic cardiomyopathy, underscoring the central role of myosin in sarcomere function and disease. Mutations in myosin genes can alter force generation and lead to cardiomyopathy [2,3]. The M band cross-links thick filaments and contributes to their stability and alignment.
Thin filaments and regulatory proteins
In simple terms: Thin filaments are the tracks that myosin pulls on, and they carry regulatory proteins that switch contraction on and off.
Thin filaments are composed of actin together with the troponin complex and tropomyosin, which regulate calcium-dependent activation of contraction [2,5]. Mutations in thin filament proteins such as cardiac troponin T can disrupt sarcomere-mitochondrial communication and cause dilated cardiomyopathy. The thin filament is therefore both a structural element and a regulatory hub [2,5].
Z disc and M band
In simple terms: The Z disc is the boundary that anchors thin filaments, and the M band is the central line that holds thick filaments together.
The Z disc defines the lateral boundaries of the sarcomere and anchors thin filaments, while the M band is a central structure that cross-links thick filaments [2,6]. The M band has been described as an underestimated part of the sarcomere that contributes to filament alignment, mechanical stability, and signaling. Disruption of these structures can impair force transmission and sarcomere integrity [2,6].
Sarcomere assembly and growth
In simple terms: Sarcomeres are not static; they are built and can even divide to help muscle grow.
Sarcomere assembly requires coordinated synthesis, folding, and incorporation of many proteins, and is regulated by post-translational systems such as SUMOylation. Recent work has shown that muscle growth can occur by sarcomere divisions, revealing a mechanism for increasing sarcomere number. These findings highlight that sarcomere organization is dynamic and subject to regulated remodeling [4,8].
Molecular mechanism of contraction
In simple terms: Contraction happens when myosin heads grab thin filaments and pull, using energy from ATP.
Contraction is driven by cyclic interactions between myosin heads and actin filaments, regulated by calcium and the troponin-tropomyosin complex [2,5]. This mechanochemical cycle converts ATP hydrolysis into force and motion. Genetic variants that alter myosin or thin filament function can change contractile properties and cause disease [2,3,7]. The sarcomere is thus a molecular machine whose dysfunction is directly linked to cardiomyopathy and myopathy [2,5].
Key Genes Involved in GO:0030017 sarcomere
The following genes encode core sarcomere proteins and are widely studied in sarcomere biology and disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYH7 | Myosin heavy chain beta, thick filament motor | Major hypertrophic and dilated cardiomyopathy gene [2,3] |
| MYBPC3 | Myosin-binding protein C, thick filament regulation | Common hypertrophic cardiomyopathy gene [2,3] |
| TNNT2 | Cardiac troponin T, thin filament regulation | Linked to dilated cardiomyopathy and sarcomere-mitochondrial communication |
| TNNI3 | Cardiac troponin I, thin filament regulation | Associated with inherited cardiomyopathies |
| TNNC1 | Cardiac troponin C, calcium sensing | Thin filament regulatory component |
| TPM1 | Tropomyosin, thin filament regulation | Thin filament gene implicated in cardiomyopathy |
| ACTC1 | Cardiac actin, thin filament core | Thin filament gene implicated in cardiomyopathy |
| TTN | Titin, elastic filament and sarcomere scaffold | Large sarcomere protein with roles in assembly and signaling [2,6] |
| NEB | Nebulin, thin filament length regulation | Skeletal muscle sarcomere protein linked to nemaline myopathy |
| ACTN2 | Alpha-actinin-2, Z disc component | Z disc structural protein |
| MYOZ2 | Myozenin-2, Z disc component | Z disc and calcineurin signaling |
| TCAP | Telethonin, Z disc component | Z disc protein implicated in myopathies |
| MYH2 | Myosin heavy chain 2, skeletal muscle | Skeletal muscle sarcomere function |
| MYH3 | Myosin heavy chain 3, developmental | Sarcomere assembly and muscle development |
| MYL2 | Regulatory myosin light chain | Thick filament regulation |
| MYL3 | Essential myosin light chain | Thick filament regulation |
| CSRP3 | Muscle LIM protein, Z disc | Z disc and cardiomyopathy |
How Is sarcomere Regulated?
Sarcomere organization and function are regulated at multiple levels. Post-translational modification by the SUMO system is a key regulator of sarcomere organization, influencing assembly and maintenance. Calcium signaling controls contraction through the troponin-tropomyosin complex [2,5]. Sarcomere-mitochondrial communication is essential for metabolic homeostasis, and disruption of this crosstalk can lead to dilated cardiomyopathy. In addition, the M band contributes to filament alignment and signaling, and its disruption affects sarcomere stability. These regulatory layers ensure that sarcomere function is matched to metabolic demand and mechanical load [1,6,8].
sarcomere and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNNT2 | Dilated cardiomyopathy via disrupted sarcomere-mitochondrial communication | Knock-in of patient variant in cardiomyocytes |
| MYH7 | Hypertrophic and dilated cardiomyopathy [2,3] | Point-mutation knock-in in iPSC-derived cardiomyocytes |
| MYBPC3 | Hypertrophic cardiomyopathy [2,3] | Knockout or truncating variant model |
| NEB | Nemaline myopathy | Knockout in skeletal muscle cells |
| TTN | Sarcomere assembly and cardiomyopathy [2,6] | Tagged knock-in for localization studies |
Inherited cardiomyopathies
Mutations in sarcomere genes are a major cause of inherited hypertrophic cardiomyopathy and dilated cardiomyopathy [2,3]. Low-penetrance sarcomere variants can contribute additive risk, complicating genetic counseling and risk prediction. Disruption of cTnT-mediated sarcomere-mitochondrial communication has been shown to result in dilated cardiomyopathy, linking sarcomere integrity to mitochondrial function. Cardiac myosin inhibitors that target the sarcomere are now used clinically for hypertrophic cardiomyopathy, demonstrating the therapeutic relevance of sarcomere biology.
Nemaline myopathy
Sarcomere dysfunction is a central feature of nemaline myopathy, a skeletal muscle disorder characterized by nemaline rods and muscle weakness. Mutations in thin filament and other sarcomere genes can impair force generation and sarcomere assembly. Research into sarcomere dysfunction in nemaline myopathy has informed broader understanding of sarcomere assembly and maintenance.
Sarcomere-mitochondrial crosstalk in disease
The sarcomere is functionally coupled to mitochondria, and disruption of this communication can cause dilated cardiomyopathy. This crosstalk is important for energy supply and metabolic homeostasis in cardiomyocytes. Understanding sarcomere-mitochondrial signaling may reveal new therapeutic targets for heart failure.
From sarcomere-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a sarcomere gene essential for contractile function? | CRISPR knockout in cardiomyocytes or skeletal muscle cells |
| Does a patient variant cause gain- or loss-of-function? | Point-mutation knock-in in iPSC-derived cardiomyocytes |
| Where does a sarcomere protein localize? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a sarcomere gene alter sarcomere assembly? | Overexpression in muscle cell lines |
| Which sarcomere genes modify disease severity? | CRISPR library screening in muscle cells |
| Does a variant disrupt sarcomere-mitochondrial communication? | Knock-in model with mitochondrial functional assays |
How to Study the sarcomere Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Sarcomere striation and protein localization | Assessing structural integrity [2,6] |
| Super-resolution microscopy | Nanoscale organization of Z disc and M band | Dissecting sarcomere substructure |
| Traction force microscopy | Contractile force | Functional testing of sarcomere variants |
| RNA sequencing | Transcriptional changes | Pathway analysis in sarcomere mutants [1,3] |
| CRISPR screening | Gene essentiality and modifiers | Identifying sarcomere regulators [2,3] |
| Proteomics | Protein composition and modifications | Mapping sarcomere interactome [6,8] |
| Mitochondrial function assays | Respiration and metabolic state | Sarcomere-mitochondrial crosstalk |
Imaging sarcomere structure
Fluorescence and super-resolution microscopy can visualize sarcomere striations, Z discs, and M bands using antibodies or tagged proteins [2,6]. Live-cell imaging enables tracking of sarcomere assembly and dynamics. These methods are essential for assessing structural consequences of sarcomere gene perturbations [2,6].
Functional contractility assays
Traction force microscopy, atomic force microscopy, and engineered heart tissue can measure force generation and contractile kinetics in sarcomere models [2,7]. These assays link molecular changes to functional outcomes [2,7].
Genomic and transcriptomic profiling
RNA sequencing and CRISPR screening can identify modifiers of sarcomere gene expression and function [2,3]. Transcriptomic profiling of sarcomere mutant models reveals downstream pathways and disease mechanisms [1,3].
Proteomics and interactomics
Mass spectrometry-based proteomics can define sarcomere protein composition, post-translational modifications, and interaction networks [6,8]. These approaches help map sarcomere assembly and regulation [6,8].
How CRISPR Can Be Used to Study GO:0030017 sarcomere
Knockout
CRISPR knockout of sarcomere genes can reveal essential roles in sarcomere assembly and contractility [2,5]. Knockout models are useful for testing loss-of-function mechanisms in cardiomyopathy and myopathy [2,5].
Point Mutation
Point-mutation knock-in models allow precise testing of patient variants in sarcomere genes, including low-penetrance variants that contribute additive risk. These models help distinguish pathogenic from benign variants.
Knock-in
Knock-in of tagged or reporter constructs enables visualization and biochemical isolation of sarcomere proteins. Knock-in models are also used to study sarcomere-mitochondrial communication.
Overexpression
Overexpression of sarcomere genes can model gain-of-function effects and test whether increased protein levels alter sarcomere organization [4,8]. Overexpression is useful for studying sarcomere assembly and growth.
How EDITGENE Supports sarcomere Research
Researchers studying sarcomere-related genes often need to determine whether a candidate gene is causally involved in sarcomere assembly, function, or disease. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for sarcomere biology.
Contact EDITGENE today to design your custom CRISPR model for sarcomere research.
Frequently Asked Questions About sarcomere
What is GO:0030017 sarcomere?
GO:0030017 sarcomere is the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs.
What genes are involved in the sarcomere?
Core sarcomere genes include MYH7, MYBPC3, TNNT2, TNNI3, TNNC1, TPM1, ACTC1, TTN, NEB, ACTN2, MYOZ2, TCAP, MYL2, MYL3, and CSRP3 [2,5,6].
Why is the sarcomere important in disease?
Sarcomere mutations cause inherited cardiomyopathies and skeletal myopathies, and sarcomere dysfunction is linked to heart failure [2,3,5].
How is the sarcomere regulated?
The sarcomere is regulated by calcium signaling, post-translational modifications such as SUMOylation, and communication with mitochondria [1,8].
What is the M band in the sarcomere?
The M band is a central sarcomere subregion that cross-links thick filaments and contributes to alignment and signaling.
Can CRISPR be used to study sarcomere genes?
Yes, CRISPR knockout, point-mutation knock-in, and overexpression models are widely used to study sarcomere gene function and disease variants [2,3].
What diseases are linked to sarcomere dysfunction?
Hypertrophic cardiomyopathy, dilated cardiomyopathy, and nemaline myopathy are linked to sarcomere dysfunction [1,2,5].
How do sarcomeres grow in muscle?
Muscle growth can occur by sarcomere divisions, increasing sarcomere number.
What methods are used to study sarcomeres?
Imaging, contractility assays, RNA sequencing, proteomics, and CRISPR screening are commonly used [2,6,8].
What is sarcomere-mitochondrial communication?
It is functional crosstalk between the sarcomere and mitochondria that supports metabolic homeostasis, and its disruption can cause dilated cardiomyopathy.
Conclusion
The sarcomere (GO:0030017) is the fundamental contractile unit of striated muscle and a central node in muscle physiology and disease. Its precise assembly and regulation depend on a large set of structural and regulatory proteins, and its dysfunction underlies inherited cardiomyopathies and myopathies [2,5]. Advances in CRISPR modeling and functional genomics now allow researchers to test sarcomere gene variants causally and to identify new therapeutic targets [2,3,7]. Continued study of sarcomere biology will be essential for translating mechanistic insight into clinical benefit.
References
- 1. Ye L et al.. 2025. Disruption of cTnT-Mediated Sarcomere-Mitochondrial Communication Results in Dilated Cardiomyopathy.. Circulation 152(6):397-415 PMID: 40421531
- 2. Lehman SJ et al.. 2022. Targeting the sarcomere in inherited cardiomyopathies.. Nat Rev Cardiol 19(6):353-363 PMID: 35304599
- 3. Meisner JK et al.. 2025. Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.. Circulation 151(11):783-798 PMID: 39633578
- 4. Rodier C et al.. 2025. Muscle growth by sarcomere divisions.. Sci Adv 11(28):eadw9445 PMID: 40632866
- 5. de Winter JM et al.. 2017. Sarcomere Dysfunction in Nemaline Myopathy.. J Neuromuscul Dis 4(2):99-113 PMID: 28436394
- 6. Lange S et al.. 2020. The M-band: The underestimated part of the sarcomere.. Biochim Biophys Acta Mol Cell Res 1867(3):118440 PMID: 30738787
- 7. Nakamura K et al.. 2025. Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: From Sarcomere to Clinic.. Int J Mol Sci 26(19) PMID: 41096616
- 8. Nayak A et al.. 2020. SUMO system - a key regulator in sarcomere organization.. FEBS J 287(11):2176-2190 PMID: 32096922
